Literature DB >> 12672454

Increased transcription of ubiquitin-proteasome system components: molecular responses associated with muscle atrophy.

S R Price1.   

Abstract

Muscle atrophy is a common consequence of catabolic conditions like kidney failure, cancer, sepsis, and acute diabetes. Loss of muscle protein is due primarily to activation of the ubiquitin-proteasome proteolytic system. The proteolytic responses to catabolic signals include increased levels of mRNA that encode various components of the system. In the case of two genes, the proteasome C3 subunit and ubiquitin UbC, the higher levels of mRNA result from increased transcription but the mechanisms of transactivation differ between them. This review summaries the evidence that cachectic signals activate a program of selective transcriptional responses in muscle that frequently occurs coordinately with increased protein destruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672454     DOI: 10.1016/s1357-2725(02)00385-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

Review 1.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

2.  Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy.

Authors:  Robson Francisco Carvalho; Eduardo Paulino Castan; Cesar Augusto Coelho; Francis Silva Lopes; Fernanda Losi Alves Almeida; Aline Michelin; Rodrigo Wagner Alves de Souza; João Pessoa Araújo; Antonio Carlos Cicogna; Maeli Dal Pai-Silva
Journal:  J Mol Histol       Date:  2010-03-28       Impact factor: 2.611

3.  Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease.

Authors:  Coen A C Ottenheijm; Leo M A Heunks; Yi-Ping Li; Bingwen Jin; Ronnie Minnaard; Hieronymus W H van Hees; P N Richard Dekhuijzen
Journal:  Am J Respir Crit Care Med       Date:  2006-08-17       Impact factor: 21.405

Review 4.  Angiotensin II, oxidative stress and skeletal muscle wasting.

Authors:  Sergiy Sukhanov; Laura Semprun-Prieto; Tadashi Yoshida; A Michael Tabony; Yusuke Higashi; Sarah Galvez; Patrice Delafontaine
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

5.  Regulation of histone deacetylase 4 expression by the SP family of transcription factors.

Authors:  Fang Liu; Nabendu Pore; Mijin Kim; K Ranh Voong; Melissa Dowling; Amit Maity; Gary D Kao
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

Review 6.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

7.  PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.

Authors:  Despina Constantin; Dumitru Constantin-Teodosiu; Robert Layfield; Kostas Tsintzas; Andrew J Bennett; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

8.  Effects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson's Disease Rat Model.

Authors:  Myoung-Ae Choe; Byung-Soo Koo; Gyeong Ju An; Songhee Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

Review 9.  Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.

Authors:  David Nury; Christine Doucet; Olivier Coux
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

10.  Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells.

Authors:  Peter G Hawkins; Sharon Santoso; Christopher Adams; Vasiliki Anest; Kevin V Morris
Journal:  Nucleic Acids Res       Date:  2009-03-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.